Representative C. Scott Franklin (R-Florida) recently sold shares of Procter & Gamble Company The) (NYSE: PG. In a filing disclosed on July 14th, the Representative disclosed that they had sold between $15,001 and $50,000 in Procter & Gamble stock on June 16th. The trade occurred in the Representative's "FIDELITY JOINT TBE" account.
Representative C. Scott Franklin also recently made the following trade(s):
- Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 6/16/2025.
- Sold $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 6/16/2025.
- Sold $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 6/16/2025.
- Sold $15,001 - $50,000 in shares of McDonald's NYSE: MCD on 6/16/2025.
- Sold $1,001 - $15,000 in shares of United Parcel Service NYSE: UPS on 6/16/2025.
- Sold $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 6/16/2025.
- Sold $15,001 - $50,000 in shares of Walmart NYSE: WMT on 6/16/2025.
- Sold $15,001 - $50,000 in shares of Berkshire Hathaway NYSE: BRK.B on 6/16/2025.
- Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 6/16/2025.
- Sold $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 6/16/2025.
Procter & Gamble Trading Down 0.3%
Procter & Gamble stock traded down $0.54 during midday trading on Friday, reaching $155.08. The stock had a trading volume of 7,270,714 shares, compared to its average volume of 7,652,310. The firm's fifty day simple moving average is $161.31 and its two-hundred day simple moving average is $164.44. The firm has a market cap of $363.59 billion, a price-to-earnings ratio of 24.62, a PEG ratio of 4.43 and a beta of 0.40. Procter & Gamble Company has a twelve month low of $151.90 and a twelve month high of $180.43. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The business had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. During the same quarter in the previous year, the firm posted $1.52 earnings per share. The firm's revenue for the quarter was down 2.1% on a year-over-year basis. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.73%. Procter & Gamble's dividend payout ratio (DPR) is presently 67.14%.
Hedge Funds Weigh In On Procter & Gamble
Institutional investors have recently added to or reduced their stakes in the business. Access Financial Services Inc. boosted its stake in Procter & Gamble by 0.6% during the 2nd quarter. Access Financial Services Inc. now owns 10,889 shares of the company's stock valued at $1,735,000 after purchasing an additional 65 shares in the last quarter. Philip James Wealth Mangement LLC lifted its position in shares of Procter & Gamble by 9.2% during the 2nd quarter. Philip James Wealth Mangement LLC now owns 5,676 shares of the company's stock valued at $904,000 after acquiring an additional 477 shares during the last quarter. Viewpoint Investment Partners Corp purchased a new stake in shares of Procter & Gamble in the second quarter valued at $360,000. Warren Street Wealth Advisors LLC lifted its holdings in shares of Procter & Gamble by 2.2% in the second quarter. Warren Street Wealth Advisors LLC now owns 3,418 shares of the company's stock valued at $545,000 after purchasing an additional 75 shares in the last quarter. Finally, Naples Global Advisors LLC lifted its holdings in shares of Procter & Gamble by 2.6% in the second quarter. Naples Global Advisors LLC now owns 46,072 shares of the company's stock valued at $7,340,000 after purchasing an additional 1,189 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer directly owned 51,965 shares of the company's stock, valued at $8,386,111.70. This trade represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the transaction, the insider owned 25,182 shares of the company's stock, valued at $3,995,627.94. This trade represents a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
PG has been the subject of a number of recent research reports. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Royal Bank Of Canada raised shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their price target for the stock from $164.00 to $177.00 in a report on Friday, April 25th. UBS Group decreased their price objective on shares of Procter & Gamble from $186.00 to $180.00 and set a "buy" rating on the stock in a research report on Thursday. Raymond James Financial decreased their price objective on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. Finally, Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the stock an "overweight" rating in a report on Friday, April 25th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $176.84.
Check Out Our Latest Stock Report on Procter & Gamble
About Representative Franklin
Scott Franklin (Republican Party) is a member of the U.S. House, representing Florida's 18th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Franklin (Republican Party) is running for re-election to the U.S. House to represent Florida's 18th Congressional District. He declared candidacy for the 2026 election.
Scott Franklin was born in Thomaston, Georgia. Franklin graduated from Lakeland High School. He served in the U.S. Navy from 1986 to 2000 and the U.S. Navy Reserve from 2000 to 2012.
Franklin earned a B.S. from the United States Naval Academy in 1986 and an M.B.A. from Embry-Riddle Aeronautical University in 1994. Franklin's career experience includes owning an insurance agency and working as a naval aviator with the U.S. Navy.
About Procter & Gamble
(
Get Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report